MX2022010413A - Compuestos de pirrolopiridina e imidazopiridina antivirales. - Google Patents

Compuestos de pirrolopiridina e imidazopiridina antivirales.

Info

Publication number
MX2022010413A
MX2022010413A MX2022010413A MX2022010413A MX2022010413A MX 2022010413 A MX2022010413 A MX 2022010413A MX 2022010413 A MX2022010413 A MX 2022010413A MX 2022010413 A MX2022010413 A MX 2022010413A MX 2022010413 A MX2022010413 A MX 2022010413A
Authority
MX
Mexico
Prior art keywords
sup
pyrrolopyridine
imidazopyridine
antiviral compounds
compounds
Prior art date
Application number
MX2022010413A
Other languages
English (en)
Inventor
Nesya Goris
Eleonora Kiss
Robert Vrancken
Original Assignee
Univ Leuven Kath
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Leuven Kath filed Critical Univ Leuven Kath
Publication of MX2022010413A publication Critical patent/MX2022010413A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A40/00Adaptation technologies in agriculture, forestry, livestock or agroalimentary production
    • Y02A40/70Adaptation technologies in agriculture, forestry, livestock or agroalimentary production in livestock or poultry

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Oncology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

La presente invención se refiere a un compuesto de la fórmula (I) o un estereoisómero, o tautómero, (ver Fórmula) (I) en la cual A1, A2, R1 y R2, tienen el mismo significado que el definido en las reivindicaciones y la descripción. La presente invención también se refiere a composiciones, en particular farmacéuticas, que comprenden dichos compuestos, y a usos de dichos compuestos y composiciones para la prevención y/o tratamiento de una infección causada por pestivirus en un animal.
MX2022010413A 2020-02-24 2021-02-24 Compuestos de pirrolopiridina e imidazopiridina antivirales. MX2022010413A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP20158958 2020-02-24
PCT/EP2021/054486 WO2021170600A1 (en) 2020-02-24 2021-02-24 Pyrrolopyridine and imidazopyridine antiviral compounds

Publications (1)

Publication Number Publication Date
MX2022010413A true MX2022010413A (es) 2022-09-07

Family

ID=69810569

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2022010413A MX2022010413A (es) 2020-02-24 2021-02-24 Compuestos de pirrolopiridina e imidazopiridina antivirales.

Country Status (9)

Country Link
US (1) US20230130598A1 (es)
EP (1) EP4110777A1 (es)
JP (1) JP2023514443A (es)
CN (1) CN115175909A (es)
AR (1) AR121403A1 (es)
AU (1) AU2021225333A1 (es)
BR (1) BR112022016733A2 (es)
MX (1) MX2022010413A (es)
WO (1) WO2021170600A1 (es)

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IS2334B (is) 1992-09-08 2008-02-15 Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) Aspartyl próteasi hemjari af nýjum flokki súlfonamíða
US6043358A (en) 1995-11-01 2000-03-28 Merck & Co., Inc. Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases
GB9718913D0 (en) 1997-09-05 1997-11-12 Glaxo Group Ltd Substituted oxindole derivatives
WO1999033792A2 (en) 1997-12-24 1999-07-08 Vertex Pharmaceuticals Incorporated Prodrugs os aspartyl protease inhibitors
CN1110492C (zh) 1997-12-24 2003-06-04 沃泰克斯药物股份有限公司 天冬氨酰蛋白酶抑制剂的前药
AU2012199A (en) 1997-12-24 1999-07-19 Vertex Pharmaceuticals Incorporated Prodrugs of aspartyl protease inhibitors
US6436989B1 (en) 1997-12-24 2002-08-20 Vertex Pharmaceuticals, Incorporated Prodrugs of aspartyl protease inhibitors
US6369087B1 (en) 1999-08-26 2002-04-09 Robert R. Whittle Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
GB0215293D0 (en) * 2002-07-03 2002-08-14 Rega Foundation Viral inhibitors
ES2381890T3 (es) * 2003-12-22 2012-06-01 K.U.Leuven Research & Development Compuesto de imidazo[4,5-c]piridina y métodos de tratamiento antiviral
SI1706403T1 (sl) * 2003-12-22 2012-08-31 Leuven K U Res & Dev Imidazo(4,5-c)piridin spojine in postopki antivirusnega zdravljenja
WO2007034277A1 (en) * 2005-09-19 2007-03-29 Pfizer Products Inc. Aryl substituted imidazo [4,5-c] pyridine compounds as c3a receptor antagonists
DK2094702T3 (en) * 2006-12-14 2015-12-07 Gilead Sciences Inc viral inhibitors

Also Published As

Publication number Publication date
BR112022016733A2 (pt) 2022-10-11
AU2021225333A1 (en) 2022-08-11
AR121403A1 (es) 2022-06-01
EP4110777A1 (en) 2023-01-04
CN115175909A (zh) 2022-10-11
JP2023514443A (ja) 2023-04-05
US20230130598A1 (en) 2023-04-27
WO2021170600A1 (en) 2021-09-02

Similar Documents

Publication Publication Date Title
MX2022010011A (es) Inhibidores de prmt5 novedosos.
MX2021014350A (es) Compuestos de 1-oxo-isoindolin-5-carboxamida sustituida, composiciones de los mismos y metodos de tratamiento con los mismos.
GEP20094847B (en) Novel phenyl-propargylether derivatives
TN2019000170A1 (en) Tetracyclic heterocycle compounds useful as hiv integrase inhibitors
MX2020011317A (es) Compuestos heterociclicos triciclicos utiles como inhibidores de la integrasa de vih.
ZA202213152B (en) Novel acid secretion inhibitor and use thereof
AU2020231934A8 (en) Compounds useful in HIV therapy
MX2020000576A (es) Compuestos quimicos.
WO2019207257A8 (fr) Composes a activite inhibitrice de la polymerisation de la tubuline et aux proprietes immunomodulatrices
MX2023006504A (es) Compuesto de hidroxamato, metodo de preparacion del mismo y aplicacion del mismo.
MX2021002188A (es) Nuevo derivado de amina heterociclica y composicion farmaceutica que la comprende.
MX2021014680A (es) Derivado de benzotriazol.
MX2020007521A (es) Inhibidores de pi4kiii.
SA521422728B1 (ar) مثبطات فوسفوينوسيتيد 3- كيناز الموضعية
PH12020552186A1 (en) Cyanotriazole compounds and uses thereof
MX2021008510A (es) Derivados de tiazolopiridina como antagonistas del receptor de adenosina.
EP4316504A3 (en) Compounds
MX2022010413A (es) Compuestos de pirrolopiridina e imidazopiridina antivirales.
WO2020251871A3 (en) Novel substituted tetrahydroquinolin compounds as indoleamine 2,3-dioxygenase (ido) inhibitors
NZ507452A (en) Hygromycin a derivatives
CA3241619A1 (en) Bifunctional arylsulphonamide compounds
CL2022003400A1 (es) Uso del inhibidor de la fosfodiesterasa a 10 para el tratamiento del síndrome de tourette
TW200640464A (en) Pharmaceutical composition comprising phenoxazinium compounds as an active ingredient
MX2022013890A (es) Sintesis y derivados de acido boronico, formas polimorficas y usos terapeuticos de los mismos.
IL159521A0 (en) Tricyclic pyridines for use in treatment of conditions mediated by crf